| 2025-10-27 | -28.7% | legal | SEC EDGAR | OGN 8-K: 5.02, 8.01 (SEC Filing) |
| 2025-05-01 | -28.0% | legal | SEC EDGAR | OGN 8-K: 2.02, 7.01, 8.01 (SEC Filing) |
| 2026-04-23 | +22.8% | news | Yahoo Finance | Organon (OGN) Dips More Than Broader Market: What You Should Know - Yahoo Finance |
| 2026-04-10 | +22.7% | news | Seeking Alpha | Organon rises as Sun Pharma said to near $12B bid (update) |
| 2026-04-10 | +22.7% | M&A | Investopedia | This Women’s Healthcare Stock Is Up 15% on Reports of a Takeover In the Works - Investopedia |
| 2026-04-10 | +22.7% | M&A | Seeking Alpha | Organon rises as Sun Pharma nears buyout deal (OGN:NYSE) - Seeking Alpha |
| 2026-04-10 | +22.7% | earnings | MarketBeat | Organon & Co. (NYSE:OGN) Shares Gap Up - Should You Buy? - MarketBeat |
| 2026-04-10 | +22.7% | M&A | MEXC | Organon (OGN) Stock Rockets 41% as Sun Pharma Submits $12B Buyout Proposal - MEXC |
| 2024-02-15 | +14.2% | legal | SEC EDGAR | OGN 8-K: 2.02, 7.01 (SEC Filing) |
| 2021-08-12 | +13.8% | legal | SEC EDGAR | OGN 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-11-07 | +13.2% | legal | SEC EDGAR | OGN 8-K: 5.02 (SEC Filing) |
| 2023-11-02 | -12.1% | legal | SEC EDGAR | OGN 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-10-28 | -10.5% | news | Yahoo Finance | Why Organon (OGN) Stock Is Down Today - Yahoo Finance |
| 2026-01-20 | +10.4% | news | Seeking Alpha | Organon gains on report of Sun Pharmaceutical interest |
| 2026-01-20 | +10.4% | news | Yahoo Finance | Why Are Organon (OGN) Shares Soaring Today - Yahoo Finance |
| 2026-01-20 | +10.4% | news | Finviz | Why Are Organon (OGN) Shares Soaring Today - Finviz |
| 2026-01-05 | +10.2% | news | Yahoo Finance | Organon (OGN) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance |
| 2025-08-05 | -10.1% | legal | SEC EDGAR | OGN 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-01-17 | +10.0% | legal | Seeking Alpha | Organon wins FDA nod to expand use of Nexplanon birth control implant |
| 2026-01-06 | +9.8% | news | simplywall.st | Great week for Organon & Co. (NYSE:OGN) institutional investors after losing 51% over the previous year - simplywall.st |
| 2023-02-16 | -9.4% | legal | SEC EDGAR | OGN 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-11-10 | +9.1% | legal | SEC EDGAR | OGN 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-11-10 | +9.1% | earnings | Yahoo Finance | Organon (OGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance |
| 2025-11-10 | +9.1% | earnings | Yahoo Finance | Organon (OGN) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance |
| 2022-05-05 | +8.9% | legal | SEC EDGAR | OGN 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-04-20 | -8.6% | earnings | MarketBeat | Organon & Co. (NYSE:OGN) Trading Down 5% - Here's What Happened - MarketBeat |
| 2026-04-20 | -8.6% | news | Cổng thông tin điện tử tỉnh Tây Ninh | Organon & (OGN) Stock Monetary Policy (Underperforming) 2026-04-20 - Trending Momentum Stocks - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-04-20 | -8.6% | news | Cổng thông tin điện tử Tỉnh Sơn La | Organon & (OGN) Stock Monetary Policy (Underperforming) 2026-04-20 - Trending Momentum Stocks - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-04-20 | -8.6% | news | Capital.com | Organon & Co (OGN) Stock Price Quote Today & Current Price Chart - Capital.com |
| 2023-05-04 | -8.2% | legal | SEC EDGAR | OGN 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-02-11 | -8.0% | earnings | Seeking Alpha | Organon Q4 Earnings Preview: Cautious view amid weak year |
| 2023-08-08 | +7.3% | legal | SEC EDGAR | OGN 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-01-24 | -7.3% | M&A | Seeking Alpha | Key deals this week: Clorox, Spirit Airlines, GSK, PayPal, and more |
| 2026-01-24 | -7.3% | news | Yahoo Finance | Assessing Organon (OGN) Valuation After A Sharp 30 Day Share Price Rebound - Yahoo Finance |
| 2025-10-30 | +7.2% | legal | SEC EDGAR | OGN 8-K: 5.02 and (SEC Filing) |
| 2025-10-30 | +7.2% | news | Yahoo Finance | Jim Cramer’s “Worst Stock Ever” Might Be Organon (OGN) - Yahoo Finance |
| 2025-10-08 | -6.7% | news | Yahoo Finance | Is There Now Opportunity in Organon Stock After Recent Double Digit Drop in 2025? - Yahoo Finance |
| 2023-12-05 | -6.7% | legal | SEC EDGAR | OGN 8-K: 5.02 (SEC Filing) |
| 2022-11-03 | -6.5% | legal | SEC EDGAR | OGN 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-02-02 | -6.0% | news | Yahoo Finance | Organon (OGN) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance |
| 2024-08-06 | -5.9% | legal | SEC EDGAR | OGN 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-02-20 | +5.6% | news | Seeking Alpha | Organon rises after update on independent review |
| 2026-02-20 | +5.6% | legal | SEC EDGAR | OGN 8-K: 8.01 and (SEC Filing) |
| 2026-02-20 | +5.6% | news | Seeking Alpha | Organon rises after update on independent review (OGN:NYSE) - Seeking Alpha |
| 2026-04-04 | -5.3% | earnings | MarketBeat | Philip James Wealth Mangement LLC Lowers Stock Position in Organon & Co. $OGN - MarketBeat |
| 2025-12-03 | -5.1% | news | Seeking Alpha | Organon & Co. (OGN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript |
| 2021-11-12 | -4.6% | legal | SEC EDGAR | OGN 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-04-16 | +4.5% | M&A | Seeking Alpha | Organon gains as Sun Pharma, Grnenthal said to seek takeover deals |
| 2026-04-16 | +4.5% | M&A | Yahoo Finance | Why Organon (OGN) Is Surging as Buyout Interest Gains Traction - Yahoo Finance |
| 2026-04-16 | +4.5% | M&A | Seeking Alpha | Organon gets buyout interest from Sun Pharma, Grünenthal (OGN) - Seeking Alpha |
| 2026-04-16 | +4.5% | earnings | MarketBeat | Organon & Co. (NYSE:OGN) Shares Gap Up - Time to Buy? - MarketBeat |
| 2026-04-16 | +4.5% | earnings | MarketBeat | Organon & Co. (NYSE:OGN) Upgraded by Zacks Research to "Hold" Rating - MarketBeat |
| 2026-04-16 | +4.5% | earnings | Stock Titan | Organon posts Q1 results May 7, then opens investor call at 8:30 ET - Stock Titan |
| 2026-04-16 | +4.5% | news | AlphaStreet | Organon & Co. (OGN) Stock Rises 4% to $9.6 - AlphaStreet |
| 2026-02-01 | -4.5% | news | Yahoo Finance | Is It Time To Reassess Organon (OGN) After Its Sharp Multi Year Share Price Slide - Yahoo Finance |
| 2026-04-06 | -4.3% | news | Yahoo Finance | Organon (OGN) Stock Sinks As Market Gains: Here's Why - Yahoo Finance |
| 2026-04-11 | -4.3% | M&A | Seeking Alpha | Key deals this week: Organon, UMG, Whitestone REIT, Gilead and more |
| 2026-04-11 | -4.3% | M&A | Yahoo Finance | Organon (OGN) Climbs 39% on $12-Billion Merger Buzz - Yahoo Finance |
| 2026-04-11 | -4.3% | news | Yahoo Finance | Morning Movers: Organon jumps after report of Sun Pharmaceutical bid - Yahoo Finance |
| 2026-04-11 | -4.3% | M&A | Seeking Alpha | Key deals this week: Organon, UMG, Whitestone REIT, Gilead and more - Seeking Alpha |
| 2025-11-17 | +4.2% | news | Yahoo Finance | Read This Before Considering Organon & Co. (NYSE:OGN) For Its Upcoming US$0.02 Dividend - Yahoo Finance |
| 2026-02-08 | -4.1% | earnings | Seeking Alpha | Earnings week ahead: F, KO, CSCO, SHOP, MCD, BP, AMAT, COIN, MRNA, ROKU, and more |
| 2026-02-08 | -4.1% | news | TIKR.com | Down 72% In 3 Years, Can Organon Stock Finally Recover In 2026? - TIKR.com |
| 2026-03-31 | +4.0% | news | Stock Titan | Organon (OGN) EVP gains shares via RSU vesting and tax withholding - Stock Titan |
| 2026-03-31 | +4.0% | news | Stock Titan | Organon (NYSE: OGN) SVP exercises RSUs; 1,516 shares withheld for tax - Stock Titan |
| 2026-03-31 | +4.0% | news | Stock Titan | [Form 4] Organon & Co. Insider Trading Activity - Stock Titan |
| 2026-03-31 | +4.0% | executive | Stock Titan | Organon (OGN) HR chief converts 8,422 RSUs; 2,885 shares withheld for taxes - Stock Titan |
| 2026-03-31 | +4.0% | executive | Stock Titan | Organon (OGN) interim manufacturing chief exercises 7,979 RSUs, nets shares - Stock Titan |
| 2026-03-31 | +4.0% | news | Stock Titan | Organon (NYSE: OGN) CIO exercises RSUs, 2,809 shares withheld for tax - Stock Titan |
| 2026-03-31 | +4.0% | news | Stock Titan | Organon (OGN) CMO nets more shares after 8,865 RSUs vest - Stock Titan |
| 2025-05-27 | +3.8% | legal | SEC EDGAR | OGN 8-K: 8.01 and (SEC Filing) |
| 2026-03-27 | -3.8% | news | Yahoo Finance | Organon (OGN) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance |
| 2021-06-03 | -3.7% | legal | SEC EDGAR | OGN 8-K: 1.01, 2.01, 2.03, 3.03, 5.02, 5.03, 5.05, 7.01 (SEC Filing) |
| 2026-04-13 | -3.7% | M&A | Seeking Alpha | Organon Takeover At $15? Probably Not, Here's Why |
| 2026-04-13 | -3.7% | news | Yahoo Finance | Organon (OGN) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance |
| 2026-04-13 | -3.7% | M&A | TIKR.com | Organon Stock Skyrockets 28% Following Reports of $12 Billion Buyout Offer From Sun Pharma - TIKR.com |
| 2026-04-13 | -3.7% | M&A | Seeking Alpha | Organon Takeover At $15? Probably Not, Here's Why (NYSE:OGN) - Seeking Alpha |
| 2026-01-29 | -3.4% | news | simplywall.st | The Market Lifts Organon & Co. (NYSE:OGN) Shares 25% But It Can Do More - simplywall.st |
| 2026-01-14 | +3.4% | news | Yahoo Finance | Organon (OGN) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance |
| 2022-08-04 | -3.0% | legal | SEC EDGAR | OGN 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-09-11 | +3.0% | news | Yahoo Finance | Why Organon (OGN) Stock Is Trading Up Today - Yahoo Finance |
| 2024-12-06 | -3.0% | legal | SEC EDGAR | OGN 8-K: 5.02 (SEC Filing) |
| 2025-02-13 | +2.9% | legal | SEC EDGAR | OGN 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-10-21 | -2.7% | news | Yahoo Finance | Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance |
| 2026-01-27 | -2.7% | news | Yahoo Finance | Organon (OGN) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance |
| 2025-12-01 | -2.6% | news | Yahoo Finance | Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance |
| 2025-11-15 | +2.5% | news | Seeking Alpha | Insider trades: Boeing, Starbucks, Merck among notable names this week |
| 2026-02-12 | -2.4% | earnings | Seeking Alpha | Organon & Co. 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-12 | -2.4% | earnings | Seeking Alpha | Organon Q4 Earnings Review: Poor Results Trigger Predictable Sell-Off |
| 2026-02-12 | -2.4% | earnings | Seeking Alpha | Organon outlines flat $6.2B revenue and $1.9B EBITDA targets for 2026 as cost controls and portfolio shifts take center stage |
| 2026-02-12 | -2.4% | earnings | Seeking Alpha | Organon & Co. (OGN) Q4 2025 Earnings Call Transcript |
| 2026-02-12 | -2.4% | news | Seeking Alpha | Organon declares $0.02 dividend |
| 2026-02-12 | -2.4% | earnings | Seeking Alpha | Organon falls as womens health unit drives Q4 miss |
| 2026-02-12 | -2.4% | earnings | Seeking Alpha | Organon in charts: Q4 revenue from Womens Health and Established Brands down; Biosimilars up Y/Y |
| 2026-02-12 | -2.4% | earnings | Seeking Alpha | Earnings Snapshot: Organon & Co. misses bottom-line estimates; initiates FY26 outlook |
| 2026-02-12 | -2.4% | earnings | Seeking Alpha | Organon Non-GAAP EPS of $0.63 misses by $0.10, revenue of $1.51B in-line |
| 2026-02-12 | -2.4% | legal | SEC EDGAR | OGN 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-02-12 | -2.4% | earnings | Yahoo Finance | Organon (NYSE:OGN) Reports Q4 CY2025 In Line With Expectations - Yahoo Finance |
| 2026-02-12 | -2.4% | earnings | Yahoo Finance | Organon (OGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance |
| 2026-02-12 | -2.4% | earnings | ChartMill | Organon & Co (NYSE:OGN) Shares Drop on Q4 Earnings Miss and Flat 2026 Outlook - ChartMill |
| 2026-01-08 | -2.4% | legal | Seeking Alpha | Organon poised to extend rally to seventh consecutive session |
| 2026-01-08 | -2.4% | news | Seeking Alpha | Organon gets Nordic and French rights to commercialize Nilemdo for dyslipidemia |
| 2026-01-08 | -2.4% | legal | Seeking Alpha | Organon poised to extend rally to seventh consecutive session - Seeking Alpha |
| 2024-10-31 | +2.3% | legal | SEC EDGAR | OGN 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-03-20 | -2.2% | news | The Motley Fool | Does This $25 Million Bet on a Stock Down 61% Signal Turnaround Potential at $6? - The Motley Fool |
| 2025-12-09 | -2.1% | news | Yahoo Finance | Why Organon (OGN) Shares Are Trading Lower Today - Yahoo Finance |
| 2022-02-17 | +2.1% | legal | SEC EDGAR | OGN 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-04-02 | -2.0% | legal | Stock Titan | OGN SEC Filings - ORGANON & CO 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2026-04-02 | -2.0% | news | Stock Titan | Organon (NYSE: OGN) EVP Daniel Karp receives 100,166 RSU grant and new shares - Stock Titan |
| 2026-04-02 | -2.0% | news | Stock Titan | [Form 4] Organon & Co. Insider Trading Activity - Stock Titan |
| 2026-04-02 | -2.0% | executive | Stock Titan | Organon (OGN) HR chief granted 166,944 RSUs and nets new shares - Stock Titan |
| 2026-04-02 | -2.0% | executive | Stock Titan | Organon (OGN) interim CEO awarded 333,889 RSUs, exercises RSUs and withholds shares for taxes - Stock Titan |
| 2026-04-02 | -2.0% | executive | Stock Titan | Organon (OGN) interim manufacturing chief granted 125,208 RSUs and exercises awards - Stock Titan |
| 2026-04-02 | -2.0% | news | Stock Titan | Organon (OGN) CMO receives 200,333 RSUs and exercises prior award - Stock Titan |
| 2026-04-02 | -2.0% | executive | Stock Titan | Organon (NYSE: OGN) CFO granted 404,840 RSUs and boosts share holdings - Stock Titan |
| 2024-05-02 | +2.0% | legal | SEC EDGAR | OGN 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-04-15 | -1.8% | legal | SEC EDGAR | OGN 8-K: 5.02 and 7.01 (SEC Filing) |
| 2026-03-10 | -1.7% | news | Seeking Alpha | Organon trades in red for seven straight sessions |
| 2026-04-21 | -1.6% | M&A | Yahoo Finance | Why Organon (OGN) Drew Buyout Buzz After a Sharp Repricing - Yahoo Finance |
| 2026-04-21 | -1.6% | earnings | MarketBeat | Organon & Co. (NYSE:OGN) Receives Average Rating of "Reduce" from Analysts - MarketBeat |
| 2026-01-15 | +1.6% | news | Yahoo Finance | Organon (OGN) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance |
| 2023-07-07 | +1.4% | legal | SEC EDGAR | OGN 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-11-14 | +1.3% | earnings | simplywall.st | Earnings Release: Here's Why Analysts Cut Their Organon & Co. (NYSE:OGN) Price Target To US$9.67 - simplywall.st |
| 2026-02-22 | -1.2% | earnings | Seeking Alpha | Organon: Revenue Decline, Margin Pressure, And Strategic Uncertainty |
| 2026-02-22 | -1.2% | earnings | Seeking Alpha | Organon: Revenue Decline, Margin Pressure, And Strategic Uncertainty - Seeking Alpha |
| 2025-10-23 | +1.0% | news | Yahoo Finance | Organon (OGN) Laps the Stock Market: Here's Why - Yahoo Finance |
| 2025-10-23 | +1.0% | news | Yahoo Finance | Assessing Organon Stock After a 39.5% Drop and Recent Portfolio Moves - Yahoo Finance |
| 2025-10-23 | +1.0% | earnings | Yahoo Finance | Organon (OGN) Earnings Expected to Grow: Should You Buy? - Yahoo Finance |
| 2024-05-17 | +0.9% | legal | SEC EDGAR | OGN 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-12-19 | +0.8% | news | Seeking Alpha | Organon: Deep Value With No Clear Catalysts |
| 2026-02-23 | +0.8% | earnings | Yahoo Finance | Organon & Co. (OGN) Posts FY Adjusted EPS of $3.66, EBITDA Margin at 30.7% - Yahoo Finance |
| 2024-12-23 | -0.7% | legal | SEC EDGAR | OGN 8-K: 8.01 (SEC Filing) |
| 2025-01-21 | -0.7% | legal | SEC EDGAR | OGN 8-K: 5.02 (SEC Filing) |
| 2026-03-17 | -0.6% | news | Yahoo Finance | A Look At Organon (OGN) Valuation After Recent Share Price Weakness - Yahoo Finance |
| 2024-09-23 | +0.3% | legal | SEC EDGAR | OGN 8-K: 1.01 and (SEC Filing) |
| 2025-06-12 | +0.3% | legal | SEC EDGAR | OGN 8-K: 5.02, 5.07 (SEC Filing) |
| 2025-11-11 | -0.3% | news | StockStory | Organon (OGN) Stock Trades Down, Here Is Why - StockStory |
| 2025-11-11 | -0.3% | news | Yahoo Finance | Is Organon’s 15% Share Price Jump a Sign of Real Value in 2025? - Yahoo Finance |
| 2026-03-18 | -0.2% | news | Seeking Alpha | Organon leads ultra-low P/E stocks at 1.8x as small-cap stocks face volatility |
| 2022-07-12 | +0.1% | legal | SEC EDGAR | OGN 8-K: 5.02 (SEC Filing) |
| 2026-03-30 | +0.0% | news | Yahoo Finance | Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance |
| 2026-04-27 | — | news | Simply Wall St. | Is It Too Late To Reassess Organon (OGN) After Its Recent Share Price Surge? |
| 2026-04-27 | — | M&A | The Wall Street Journal | Sun Pharma to Buy U.S. Healthcare Firm Organon in $11.75 Billion Deal |
| 2026-04-27 | — | M&A | Reuters | India's Sun Pharma to buy US-listed Organon in $11.75 billion deal |
| 2026-04-27 | — | M&A | Seeking Alpha | Sun Pharma to buy Organon in $11.75B deal, expanding global reach |
| 2026-04-27 | — | M&A | Seeking Alpha | Sun Pharma to buy Organon in $11.75B deal, expanding global reach (OGN:NYSE) - Seeking Alpha |
| 2026-04-27 | — | news | MSN | Organon & Co. (OGN) is attracting investor attention: Here is what you should know - MSN |
| 2026-04-27 | — | M&A | Stocktwits | OGN Stock Set For Blastoff? Sun Pharma Offers 24% Premium In All-Cash Buyout Deal - Stocktwits |
| 2026-04-26 | — | M&A | Business Wire | Sun Pharma signs Definitive Agreement to Acquire Organon |
| 2026-04-26 | — | M&A | Stock Titan | $11.75B drug deal would put Sun Pharma in 150 countries - Stock Titan |
| 2026-04-25 | — | M&A | Insider Monkey | Organon (OGN) Takeover Bid Climbs to $13B, Shares Soar 30.9% |
| 2026-04-25 | — | M&A | Seeking Alpha | Organon: What The Buyout Rumors Mean For The Stock |
| 2026-04-25 | — | M&A | Yahoo Finance | Organon (OGN) Takeover Bid Climbs to $13B, Shares Soar 30.9% - Yahoo Finance |
| 2026-04-25 | — | M&A | Seeking Alpha | Organon: What The Buyout Rumors Mean For The Stock (NYSE:OGN) - Seeking Alpha |
| 2026-04-24 | — | M&A | Barrons.com | Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma |
| 2026-04-24 | — | news | Barrons.com | These Stocks Are Today’s Movers: Intel, Nvidia, AMD, Organon, Charter, X-Energy, Newmont, Meta, and More |
| 2026-04-24 | — | legal | MT Newswires | Sector Update: Health Care Stocks Fall Late Afternoon |
| 2026-04-24 | — | legal | MT Newswires | Sector Update: Health Care Stocks Decline in Afternoon Trading |
| 2026-04-24 | — | news | 24/7 Wall St. | Nasdaq Composite Rises on Cautious Optimism on Tech Tailwinds but Iran Tensions Loom |
| 2026-04-24 | — | M&A | Seeking Alpha | Organon climbs amid reports of $13B buyout bid from Sun Pharma |
| 2026-04-24 | — | M&A | Barron's | Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma - Barron's |
| 2026-04-24 | — | news | Investing.com | Organon shares surge on report of Sun Pharma preparing $13 bln offer - Investing.com |
| 2026-04-24 | — | earnings | MarketBeat | Organon & Co. (NYSE:OGN) Shares Gap Up - Should You Buy? - MarketBeat |
| 2026-04-24 | — | M&A | Quiver Quantitative | Organon shares jump on renewed takeover chatter tied to a reported Sun Pharma bid | OGN Stock News - Quiver Quantitative |
| 2026-04-24 | — | M&A | Seeking Alpha | Organon stock climbs amid buyout rumors (OGN:NYSE) - Seeking Alpha |
| 2026-04-24 | — | M&A | Yahoo Finance | Evercore ISI Says Sun Pharma Deal Talk for Organon & Co. (OGN) Lacks Confirmation, Remains Speculative - Yahoo Finance |
| 2026-04-24 | — | M&A | MEXC | Organon (OGN) Stock Surges 25% on $13B Sun Pharma Takeover Report - MEXC |
| 2026-04-24 | — | M&A | TechStock² | Organon Stock Jumps as Sun Pharma’s Reported $13 Billion Bid Puts OGN in Takeover Spotlight - TechStock² |
| 2026-04-24 | — | M&A | StocksToTrade | Organon Stock Surges As Traders Bet On $12B Takeover - StocksToTrade |
| 2026-04-24 | — | M&A | MEXC | Organon (OGN) Stock Skyrockets 25% on Sun Pharma’s $13 Billion Buyout Offer - MEXC |
| 2026-04-24 | — | news | Stock Titan | Organon (OGN) 2026 proxy: board diversity, 2025 results and ESG strategy - Stock Titan |
| 2026-04-24 | — | M&A | timothysykes.com | Organon Stock Surges As Takeover Buzz And VTAMA News Collide - timothysykes.com |
| 2026-04-24 | — | M&A | Blockonomi | Organon (OGN) Stock Skyrockets 25% on Sun Pharma’s $13 Billion Buyout Offer - Blockonomi |